Cognitive dysfunction in patients with schizophrenia is connected with aberrant tyrosine transport

被引：0
|
作者：
Wiesel, FA
Edman, G
Eriksson, Å
Flyckt, L
Nyman, H
Venizelos, N
Bjerkenstedt, L
机构：
[1] Univ Uppsala, Dept Neurosci, S-75105 Uppsala, Sweden
[2] Karolinska Inst, Dept Psychiat, R&D Sect, S-10401 Stockholm, Sweden
[3] Karolinska Inst, Dept Clin Neurosci, S-10401 Stockholm, Sweden
来源：
SCHIZOPHRENIA RESEARCH | 2004年 / 67卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：126 / 126
页数：1
相关论文
共 50 条
  • [41] Cognitive dysfunction in schizophrenia: The psychomotor component
    Van Hecke, J
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 247 - 248
  • [42] AN APPROACH TO PSYCHOTHERAPY OF COGNITIVE DYSFUNCTION IN SCHIZOPHRENIA
    CHAPMAN, J
    MCGHIE, A
    BRITISH JOURNAL OF MEDICAL PSYCHOLOGY, 1963, 36 (03): : 253 - &
  • [43] Brain rhythms and cognitive dysfunction in schizophrenia
    Strelets, V. B.
    Garakh, Z. V.
    Novototsky-Vlasov, V. Ju.
    Magomedov, R. A.
    INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, 2008, 69 (03) : 186 - 186
  • [44] CNS catecholamines and cognitive dysfunction in schizophrenia
    Carter, CS
    Barch, D
    Cohen, JD
    Braver, T
    SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 211 - 211
  • [45] Insight, cognitive dysfunction and symptomatology in schizophrenia
    Monteiro L.C.
    Silva V.A.
    Louzã M.R.
    European Archives of Psychiatry and Clinical Neuroscience, 2008, 258 (7) : 402 - 405
  • [46] ABERRANT AMINO ACID TRANSPORT IN PATIENTS WITH SCHIZOPHRENIA, BIPOLAR-I DISORDER AND AUTISM
    Venizelos, N.
    PSYCHIATRY AND THE NEUROSCIENCES: INTERNATIONAL PERSPECTIVES, 2011, : 155 - 161
  • [47] Cognitive dysfunction and clinical complaints in schizophrenia
    Weiss, KM
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 187 - 188
  • [48] Proximate markers of cognitive dysfunction in schizophrenia
    Grover, Shrey
    Keshavan, Matcheri S.
    Lizano, Paulo L.
    Reinhart, Robert M. G.
    SCHIZOPHRENIA RESEARCH, 2021, 233 : 114 - 115
  • [49] GOTTA GET YOURSELF CONNECTED: ABERRANT WHITE MATTER DEVELOPMENT IN SCHIZOPHRENIA
    Seal, Marc
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2010, 44 : A8 - A8
  • [50] Cognitive Dysfunction Associated with Tyrosine Kinase Inhibitors in Patients with CML in Chronic Phase
    Schoenbeck, Kelly L.
    Tummala, Sirisha
    Goyal, Neha G.
    Smith, Catherine C.
    Shah, Neil P.
    BLOOD, 2020, 136
12345